| Category | Details |
|---|---|
| Peptide Name | Tirzepatide |
| Type | Dual GLP-1 / GIP Receptor Agonist |
| Structure | Synthetic incretin mimetic peptide designed to activate GLP-1 and GIP receptors |
| Primary Research Focus | Metabolic signaling, glucose regulation, and endocrine system research |
| Mechanism of Action | Activates GLP-1 and GIP receptors involved in metabolic pathways that influence insulin signaling, appetite regulation, and energy metabolism |
| Research Areas |
• Metabolic signaling research • Glucose regulation studies • Appetite and energy balance research • Endocrine and metabolic pathway investigation |
| Typical Form | Lyophilized powder for reconstitution |
| Storage | Store refrigerated after reconstitution (2-8°C) |
| Half Life | Approximately 5 days in research models |
| Purity | ≥99% (research grade) |
| Common Available Sizes | 5mg, 10mg, 15mg, 30mg, 40mg, 50mg, 60mg |
| Stability | Stable when stored properly and protected from light |
| Important Notice | For research use only. Not for human consumption. |

